[{"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q2_USD":189800000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-2000000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_2_Q2_USD":-4400000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q2_USD":-1800000.0,"OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_2_Q2_USD":200000.0,"OtherComprehensiveIncomeDefinedBenefitPlansNetUnamortizedGainLossArisingDuringPeriodNetOfTax_1_Q2_USD":0.0,"OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-500000.0,"OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":-200000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-4900000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":-2000000.0,"OtherAssetsNoncurrent_0_Q2_USD":177000000.0,"OtherAssetsCurrent_0_Q2_USD":87100000.0,"OperatingIncomeLoss_2_Q2_USD":157400000.0,"OperatingIncomeLoss_1_Q2_USD":222200000.0,"NumberOfOperatingSegments_2_Q2_segment":1.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":-4900000.0,"NonoperatingIncomeExpense_2_Q2_USD":91600000.0,"NetIncomeLoss_2_Q2_USD":200900000.0,"NetIncomeLoss_1_Q2_USD":172600000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":238000000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-55200000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":20700000.0,"MarketableSecuritiesNoncurrent_0_Q2_USD":1325400000.0,"MarketableSecuritiesCurrent_0_Q2_USD":1025300000.0,"LongTermLineOfCredit_0_Q2_USD":800000000.0,"LiabilitiesCurrent_0_Q2_USD":311400000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":4844900000.0,"Liabilities_0_Q2_USD":1205400000.0,"InvestmentIncomeInterest_2_Q2_USD":8700000.0,"InvestmentIncomeInterest_1_Q2_USD":4000000.0,"InventoryWorkInProcessNetOfReserves_0_Q2_USD":30100000.0,"NonoperatingIncomeExpense_1_Q2_USD":-5700000.0,"OtherLiabilitiesCurrent_0_Q2_USD":24800000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":94000000.0,"OtherNoncashIncomeExpense_2_Q2_USD":3000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":47300000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":46900000.0,"TreasuryStockCommonValue_0_Q2_USD":2579200000.0,"TreasuryStockCommonShares_0_Q2_shares":26619216.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":28300000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":10800000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2_Q2_USD":2800000.0,"StockholdersEquity_0_Q2_USD":3639500000.0,"ShareBasedCompensation_2_Q2_USD":69200000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":825600000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":446500000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":4040100000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":378000000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":74300000.0,"RepaymentsOfLinesOfCredit_2_Q2_USD":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":715700000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":1043000000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-2700000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":94500000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":10400000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":869400000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":26900000.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.01,"InventoryRawMaterialsNetOfReserves_0_Q2_USD":15000000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"PreferredStockValue_0_Q2_USD":0.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans_2_Q2_USD":2800000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":694900000.0,"ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_2_Q2_USD":45100000.0,"ProceedsFromSaleOfTradingSecuritiesHeldforinvestment_2_Q2_USD":108900000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":28300000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"InventoryNet_0_Q2_USD":89900000.0,"InventoryFinishedGoodsNetOfReserves_0_Q2_USD":44800000.0,"InterestPaidNet_2_Q2_USD":8100000.0,"CommonStockSharesOutstanding_0_Q2_shares":44890652.0,"CommonStockSharesIssued_0_Q2_shares":71509868.0,"CommonStockSharesAuthorized_0_Q2_shares":245000000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.01,"CommitmentsAndContingencies_0_Q2_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":203500000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":942200000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":942200000.0,"CapitalExpendituresIncurredButNotYetPaid_2_Q2_USD":3300000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":2285700000.0,"AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_0_Q2_USD":960300000.0,"AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_0_Q2_USD":956500000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":2279200000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":900000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":7400000.0,"AssetsCurrent_0_Q2_USD":2317900000.0,"Assets_0_Q2_USD":4844900000.0,"AccountsReceivableNetCurrent_0_Q2_USD":173400000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":327300000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-18600000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":2196500000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_2_Q2_USD":10400000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q2_USD":200000.0,"CommonStockValue_0_Q2_USD":700000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":12700000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":29100000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":69200000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q2_USD":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q2_shares":0.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":100000.0,"AssetImpairmentCharges_2_Q2_USD":17000000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":27100000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":44800000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":170800000.0,"CostOfGoodsAndServicesSold_1_Q2_USD":37200000.0,"InterestExpense_2_Q2_USD":9300000.0,"InterestExpense_1_Q2_USD":4700000.0,"IntangibleAssetsNetIncludingGoodwill_0_Q2_USD":44700000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_2_Q2_shares":2200000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q2_shares":2500000.0,"IncreaseDecreaseInOtherOperatingCapitalNet_2_Q2_USD":81700000.0,"IncreaseDecreaseInInventories_2_Q2_USD":-800000.0,"IncreaseDecreaseInAccountsReceivable_2_Q2_USD":16100000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2_Q2_USD":2200000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":48100000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":43900000.0,"IncomeTaxesPaidNet_2_Q2_USD":85400000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":249000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":216500000.0,"GoodwillGross_0_Q2_USD":28000000.0,"Goodwill_0_Q2_USD":28000000.0,"GainOnSaleOfInvestments_2_Q2_USD":91900000.0,"CostOfGoodsAndServicesSold_2_Q2_USD":60200000.0,"CostsAndExpenses_1_Q2_USD":224300000.0,"CostsAndExpenses_2_Q2_USD":668200000.0,"DeferredIncomeTaxAssetsNet_0_Q2_USD":264200000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":24900000.0,"EarningsPerShareBasic_1_Q2_USD":3.85,"ComprehensiveIncomeNetOfTax_2_Q2_USD":196500000.0,"EarningsPerShareBasic_2_Q2_USD":4.49,"EarningsPerShareDiluted_2_Q2_USD":4.28,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.19,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_0_Q2_USD":35400000.0,"EquityMethodInvestmentRealizedGainLossOnDisposal_2_Q2_USD":91900000.0,"EquitySecuritiesFvNi_0_Q2_USD":65000000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q2_USD":5500000.0,"EarningsPerShareDiluted_1_Q2_USD":3.65,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":44700000.0,"Ticker":"UTHR","CIK":"1082554","name":"UNITED THERAPEUTICS CORP","OfficialName":"United Therapeutics Corporation Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"8315138472.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210804"}]